Scholarly Index
Jeff P. Sharman
Willamette Valley Cancer Institute and Research Center; 15,308 total citations; 382 total publications; best world rank #47
Willamette Valley Cancer Institute and Research Center
15,308Total citations
382Total publications
45H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Medical Genetics | Lifetime | 288 | US 144 | 97.54 |
| Pathology and Forensic Medicine | Lifetime | 667 | US 305 | 97.00 |
| Medical Genetics | 2021-2025 | 47 | US 22 | 98.84 |
| Pathology and Forensic Medicine | 2021-2025 | 116 | US 45 | 97.34 |
| Oncology | 2021-2025 | 933 | US 394 | 83.14 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 678 | US 312 | 98.32 |
| Lymphoma Diagnosis and Treatment | Lifetime | 784 | US 344 | 98.19 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 497 | US 235 | 97.79 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 706 | US 295 | 97.29 |
| Advanced Breast Cancer Therapies | Lifetime | 834 | US 351 | 93.58 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 80 | US 39 | 98.88 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 99 | US 49 | 98.91 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 162 | US 51 | 95.72 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 206 | US 108 | 96.32 |
| Advanced Breast Cancer Therapies | 2021-2025 | 777 | US 270 | 85.96 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 584 | US 222 | 79.92 |